BIO-RAD LABORATORIES, INC. Debt Securities, Trading, and Equity Securities, FV-NI
BIO-RAD LABORATORIES, INC. (BIO) had Debt Securities, Trading, and Equity Securities, FV-NI of $369.90 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:TradingSecurities · last filed 2026-08-04
- 2025-12-31: Debt Securities, Trading, and Equity Securities, FV-NI 400.00M EUR.
- 2024-12-31: Debt Securities, Trading, and Equity Securities, FV-NI 400.00M EUR.
- 2023-12-31: Debt Securities, Trading, and Equity Securities, FV-NI 400.00M EUR.
- 2022-12-31: Debt Securities, Trading, and Equity Securities, FV-NI 400.00M EUR.
EUR
| Period end | Debt Securities, Trading, and Equity Securities, FV-NI |
|---|---|
| 2025-12-31 | 400.00M EUR 10-K · filed 2026-02-13 |
| 2024-12-31 | 400.00M EUR 10-K · filed 2025-02-14 |
| 2023-12-31 | 400.00M EUR 10-K · filed 2024-02-16 |
| 2022-12-31 | 400.00M EUR 10-K · filed 2023-02-17 |
| 2021-12-31 | 400.00M EUR 10-K · filed 2022-02-11 |
USD
| Period end | Debt Securities, Trading, and Equity Securities, FV-NI |
|---|---|
| 2026-06-30 | $369.90M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $359.10M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $373.40M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $364.60M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $364.40M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $336.50M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $317.50M 10-K · filed 2026-02-13 |
| 2024-09-30 | $343.50M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $305.60M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $330.60M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $325.70M 10-K · filed 2025-02-14 |
| 2023-09-30 | $290.50M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $304.90M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $324.50M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $322.60M 10-K · filed 2024-02-16 |
| 2022-09-30 | $247.70M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $286.70M 10-Q · filed 2022-07-29 |
| 2021-12-31 | $443.10M 10-K · filed 2023-02-17 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-11 |